Roche Holding Ltd
News and overview for Roche Holding Ltd
PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction [Press Release]
PRNewswire | 21 days 22 hours 33 minutes ago
...certain rights under its non-exclusive license agreements with Genentech, Inc., a wholly-owned subsidiary of Roche Holding, Ltd., including the right to receive 60% of the royalties from sales of Avastin(R) (Bevacizumab), Herceptin...
PDL BioPharma Announces Pricing of $300,000,000 Securitization Transaction [Press Release]
PRNewswire | 27 days 9 hours 17 minutes ago
...certain rights under its non-exclusive license agreements with Genentech, Inc., a wholly-owned subsidiary of Roche Holding, Ltd., including the right to receive 60% of the royalties from sales of Avastin(R) (Bevacizumab), Herceptin...
Alexandria Real Estate Equities, Inc. Reports Third Quarter 2009 Operating and Financial Results [Press Release]
PRNewswire | 19 days 6 hours 18 minutes ago
PASADENA, Calif., Nov. 5 /PRNewswire-FirstCall/ --
Facet Biotech Reports Third Quarter 2009 Financial Results [Press Release]
MarketWire | 20 days 22 hours 46 minutes ago
REDWOOD CITY, CA -- (Marketwire) -- 11/03/09 -- Facet Biotech Corporation (NASDAQ: FACT) today reported financial results for the third quarter ended September 30, 2009.
Alexandria Real Estate Equities, Inc. Reports Second Quarter 2009 Operating And Financial Results [Press Release]
PRNewswire | 110 days 13 hours 16 minutes ago
PASADENA, Calif., Aug. 6 /PRNewswire-FirstCall/ --
Wildly pink: The OTC market cleans up
Canada.com | 14 days 13 hours 41 minutes ago
As U.S. lawmakers mull a crackdown on murky trading activities such as dark pools and high-frequency trading, another unregulated sector of the market known as the Wild West of stock trading is cleaning up its own act.
Trading's Wild West cleans up its act -- with caveats
Canada.com | 14 days 3 hours 33 minutes ago
As U.S. lawmakers mull a crackdown on murky trading activities such as dark pools and high-frequency trading, another unregulated sector of the market known as the Wild West of stock trading is cleaning up its own act.
Layoffs reported at Google-backed 23andMe
American City Business Journals | 25 days 12 hours 19 minutes ago
Personal genomics company 23andMe Inc. has reportedly let go of a number of workers.
Swiss Stocks Rise, Led by ABB, Roche, Actelion, Zurich Financial Shares
Bloomberg | 43 days 12 hours 40 minutes ago
Oct. 12 (Bloomberg) -- Swiss stocks climbed after the Netherlands' Royal Philips Electronics NV unexpectedly posted a quarterly profit, fueling speculation the earnings season in Europe will show positive surprises.
Tuesday's biggest gaining and declining stocks Movers & Shakers - MarketWatch
MarketWatch | 7 days 13 hours 19 minutes ago
Did the stock market do something even more bullish than simply go up when the S&P 500 Index closed on Monday decisively above the 1,100 level?
Reportlinker Adds United States Medical Equipment Markets: Investment Opportunities, Analysis and Forecasts in Medical Devices to 2012 Report [Press Release]
Business Wire | 42 days 11 hours 31 minutes ago
Reportlinker.com announces that a new market research report is available in its catalogue.
2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer [Press Release]
PRNewswire | 7 days 20 hours 47 minutes ago
NEW YORK, Nov. 16 /PRNewswire/ -- MZ Consult NY (
2010 IR Global Rankings with FREE and PAID options: FINAL Registration Deadline is Today [Press Release]
PRNewswire | 25 days 9 hours 48 minutes ago
NEW YORK, Oct. 30 /PRNewswire/ -- MZ Consult NY (
Time Is Running Out to Have Your IR Program Independently Evaluated! [Press Release]
PRNewswire | 27 days 2 hours 39 minutes ago
New YORK, Oct. 28 /PRNewswire/ -- MZ Consult NY (
Don't Miss Out! The Registration Period for the 2010 IR Global Rankings Ends TOMORROW! [Press Release]
PRNewswire | 26 days 7 hours 44 minutes ago
NEW YORK, Oct. 29 /PRNewswire/ -- MZ Consult NY (
Sign up for CTIA SmartBrief
Company Overview
| Company: | Roche Holding Ltd |
|---|---|
| Industry: | Pharmaceuticals Manufacturers |
| Website: | http://www.roche.com |
Roche is on a roll. The company operates two segments, pharmaceuticals and diagnostics, and sells its products in more than 150 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan and Herceptin, anemia treatment NeoRecormon/Epogin, hepatitis drug Pegasys, transplant drug CellCept, obesity treatment Xenical, and Tamiflu, which is used to prevent and treat influenza, including avian strains. The company markets many of its bestsellers through subsidiary Genentech and affiliate Chugai Pharmaceutical. Roche's diagnostics arm offers advanced DNA tests, diabetes monitoring supplies, and point-of-care diagnostics used in a variety of health care settings.
Key Numbers
| Sales in U.S. Dollars (mil.) | 45,355.5 (2008) |
|---|---|
| One-year % Growth in Sales | 10.8 (2008) |
| Net Income in U.S. Dollars (mil.) | 10,267.1 (2008) |
| One-year % Growth in Net Income | 1.1 (2008) |
| Number of Employees | 78,604 (2007) |
| One-year % Growth in Number of Employees | 5.7 (2007) |
| Fiscal Year-End | December |